An immunotherapy conceived at Stanford appeared safe in an early clinical trial. Half of the participants responded positively to the treatment, aimed at triggering macrophages to engulf cancer cells, the researchers reported.
Over 400,000 people have enrolled in a study being conducted by researchers at Stanford and Apple to determine whether a wearable technology can identify irregular heart rhythms suggestive of atrial fibrillation.
Stanford scientists and their collaborators have identified two key genes responsible for the rapid growth of deer antlers. They hope their insights will open the door to new approaches for treating bone diseases and fractures.
Just 28 when she received a new heart at Stanford Hospital in 1991, Yolanda Ishaq went on to become the first heart transplant recipient to have a child at Stanford.